Oesophageal varices — screening & primary prophylaxis
Variceal prophylaxis · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Cirrhosis warrants assessment for varices and primary prophylaxis of high-risk varices to prevent first bleeding; non-selective beta-blockers (including carvedilol) or band ligation are used based on variceal size and risk.
Red flags
- Any haematemesis or melaena (acute variceal bleed)
- Large varices with red signs
- Decompensation (ascites, encephalopathy)
- Hypotension limiting beta-blockade
Assessment
Differential diagnosis
- Gastric varices
- Portal hypertensive gastropathy
- Non-cirrhotic portal hypertension
- Peptic ulcer (bleeding source)
- GAVE
Investigations
- Assess for clinically significant portal hypertension (platelet count, liver stiffness)
- Screening upper GI endoscopy where indicated (Baveno criteria)
- Transient elastography (liver stiffness) ± spleen stiffness
- FBC (platelets), LFTs, Child-Pugh/MELD
- Ultrasound for splenomegaly/portosystemic collaterals
Management
- Identify patients with compensated cirrhosis and assess for clinically significant portal hypertension
- Apply Baveno criteria — patients with low liver stiffness and normal platelets can avoid screening endoscopy
- Perform screening endoscopy where portal hypertension is likely or criteria not met
- Grade varices (small vs medium/large) and look for high-risk stigmata (red signs)
- Start a non-selective beta-blocker (carvedilol preferred) for primary prophylaxis of high-risk varices
- Titrate beta-blocker to heart rate ~55–60 bpm as tolerated, monitoring blood pressure
- Offer endoscopic variceal band ligation if beta-blockers are contraindicated or not tolerated
- Use carvedilol also to reduce decompensation in compensated significant portal hypertension
- Avoid combining beta-blocker and banding routinely for primary prophylaxis
- Re-scope at defined intervals if no prophylaxis started, adjusting as varices progress
- Treat the underlying liver disease and reinforce abstinence/weight loss to reduce portal pressure
Drugs & doses
Carvedilol 6.25 mg PO once daily, up to 12.5 mg/day (preferred NSBB)
Propranolol 40 mg PO twice daily, titrated to heart rate ~55–60
Nadolol 40 mg PO once daily (alternative)
Disposition
Outpatient hepatology surveillance; endoscopy service for banding where indicated.
Complications & pitfalls
- First variceal haemorrhage
- Beta-blocker intolerance (hypotension, bradycardia)
- Banding-induced ulcer bleeding
- Progression to decompensated cirrhosis
Exam pearls
- Carvedilol is the preferred non-selective beta-blocker and also reduces decompensation in compensated significant portal hypertension
- Baveno criteria (platelets >150, liver stiffness <20 kPa) let many patients safely skip screening endoscopy
- For primary prophylaxis choose EITHER a beta-blocker OR banding, not both
- Beta-blockers protect against first bleed; stop/hold them in refractory ascites with hypotension
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.